英格兰移植中心人群队列分析提示肾移植后主要不良心血管事件
该研究回顾性分析了2002年4月1日至2018年3月31日英格兰所有符合条件的肾移植手术,随访至2019年8月31日。在30,325例受者中,781例在移植后第一年内发生主要不良心血管事件(MACE),占2.6%;其中201例发生在移植手术的索引住院期间。第一年内发生非致死性MACE与长期死亡风险显著相关(HR 2.59,95%CI 2.34-2.88)。
要点
- 肾移植后第一年MACE发生率为2.6%(781/30,325),其中25.7%发生在移植索引住院期间。
- 第一年发生非致死性MACE者1、3、5、10年生存率分别为80.5%、70.2%、59.5%、38.6%,未发生者为97.4%、94.4%、90.7%、78.4%。
- 校正后第一年非致死性MACE与长期死亡风险相关(HR 2.59,95%CI 2.34-2.88)。
核心结论
- 肾移植后MACE并非良性事件,与长期死亡风险强相关;英格兰报告的MACE发生率显著低于北美报告。
研究设计与样本
- 回顾性研究纳入2002年4月1日至2018年3月31日英格兰所有符合条件的肾移植手术,随访至2019年8月31日,共30,325例受者。
主要发现
- 30,325例肾移植受者中,第一年内781例发生MACE,占所有肾移植手术的2.6%。
- 781例MACE中201例发生在肾移植手术的索引住院期间,占所有第一年MACE的25.7%,占所有肾移植手术的0.7%。
- 第一年内发生非致死性MACE者1年、3年、5年、10年患者生存率分别为80.5%、70.2%、59.5%、38.6%,未发生MACE者分别为97.4%、94.4%、90.7%、78.4%。
- 校正Cox比例风险模型中,移植后第一年内非致死性MACE与显著长期死亡风险相关(HR 2.59;95%CI 2.34-2.88)。
- 索引住院期间发生MACE与后续住院期间发生MACE的受者在年龄、性别和既往心脏病史上存在差异,但患者生存率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major adverse cardiovascular event (MACE) rates immediately after kidney transplantation remain uncertain due to heterogeneous reporting in the literature. To clarify this, we retrospectively studied every eligible kidney transplant procedure performed in England between April 1, 2002 and March 31, 2018, with follow-up through August 31, 2019. The primary outcome of interest was MACE broadly defined as any hospital admission with myocardial infarction, stroke, unstable angina, heart failure, any coronary revascularisation procedure and/or any cardiovascular death. Among 30,325 kidney transplant recipients, MACE occurred in 781 within the first year after transplantation (2.6% of all kidney transplant procedures). Of these 781 events, 201 occurred during the index admission for kidney transplantation surgery representing 25.7% of all first-year MACE and 0.7% of all kidney transplant procedures. Kidney transplant recipients who suffered a non-fatal MACE within the first year had significantly decreased 1-, 3-, 5- and 10-year patient survival of 80.5%, 70.2%, 59.5% and 38.6% respectively, compared to 97.4%, 94.4%, 90.7% and 78.4% for kidney transplant recipients not developing MACE. In an adjusted Cox proportional hazard model, non-fatal MACE within the first-year post-transplant was associated with significant long-term mortality risk (hazard ratio 2.59; 95% confidence interval 2.34-2.88). Kidney transplant recipients experiencing MACE during the index admission compared to subsequent admissions were differentiated by age, sex and previous cardiac history but had similar patient survival. These rates are significantly lower than those reported in North America. Thus, our data confirm MACE is not a benign post-transplant event and has a strong association with long-term mortality risk.
引用
- Anderson B, Qasim M, Evison F, et al. A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation. Kidney Int. 2022. PMID: 35716956. doi:10.1016/j.kint.2022.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。